IP Library Granted Patent US 9,109,041
Granted Patent B2
US 9,109,041 · App. 11/579,615 · Granted Aug 18, 2015

Analog compounds of analgesic peptides derived from the venom of

Inventors: Yara Cury (Santana de Parnaiba, BR); Gisele Picolo (São Paulo, BR); Katsuhiro Konno (São Paulo, BR); Renata Giorgi (São Paulo, BR); Patricia Brigatte (São Paulo, BR); Vanessa Gutierrez (São Paulo, BR); Antônio Camargo (São Paulo, BR)
Assignees: Yara Cury; Fundacão De Amparo À Pesquisa Do Estado De São Paulo; Laboratório Biosintetica Ltda.
C07K14/46C07K7/08A61K38/00G01N2800/2842
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,109,041
App. No.
11/579,615
Granted
Aug 18, 2015
Kind
B2
Abstract

The present invention refers to analog compounds of peptides having the amino acid sequences SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3 or SEQ ID NO: 4, including analgesic peptides derived from snakes of species such as Crotalus durissus terrificus ; their uses in the treatment, diagnosis and prevention of painful conditions or mediated by opioid receptors, their pharmaceutical compositions and their methods of preparation and purification, including their uses in the identification of analgesic compounds.

Claims (4)

1. A purified peptide comprising the amino acid sequence: Xaa-Phe-Ser-Pro-Glu-Asn-Cys-Gln-Gly-Glu-Ser-Lys-Pro-Cys (SEQ ID NO:3), wherein Xaa is pyroglutamate; and wherein the cysteine residues in positions 7 and 14 are linked by an intramolecular disulfide bridge; or a salt thereof, wherein the peptide is capable of causing analgesia in a subject.

2. A pharmaceutical composition comprising the peptide of claim 1 .

3. A process for producing the peptide of claim 1 , wherein the process comprises peptide synthesis in solid phase.

4. A method of treating or diagnosing pain in a subject in need thereof, the method comprising administering to the subject an effective amount of the pharmaceutical composition of claim 2 .

Assignments (4)
CORRECTIVE ASSIGNMENT TO CORRECT THE NAME OF THIRD ASSIGNEE PREVIOUSLY RECORDED AT REEL: 022991 FRAME: 0805. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Jul 2, 2015
From: CURY, YARA; PICOLO, GISELE; KONNO, KATSUHIRO; GIORGI, RENATA; BRIGATTE, PATRICIA; GUTIERREZ, VANESSA; CAMARGO, ANTONIO
To: CURY, YARA; FUNDACAO DE AMPARO A PESQUISA DO ESTADO DE SAO PAULO; LABORATORIOS BIOSINTETICA LTDA.
Reel/Frame 036050/0779 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 13, 2015
From: BIOSINTETICA FARMACEUTICA LTDA.
To: BIOLAB SANUS FARMACEUTICA LTDA.
Reel/Frame 035627/0110 →
CHANGE OF NAME Recorded May 13, 2015
From: LABORATÓRIOS BIOSINTÉTICA LTDA
To: BIOSINTÉTICA FARMACÊUTICA LTDA.
Reel/Frame 035652/0582 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 22, 2009
From: CURY, YARA; PICOLO, GISELE; KONNO, KATSUHIRO; GIORGI, RENATA; BRIGATTE, PATRICIA; GUTIERREZ, VANESSA; CAMARGO, ANTONIO
To: CURY, YARA; FUNDACAO DE AMPARO A PESQUISA DO ESTADO DE SAO PAULO; LABORATORIO BIOSINTETICA LTDA.
Reel/Frame 022991/0805 →
Priority Claims (2)
BR 0401702 · May 6, 2004 · national
BR 0502399 · May 2, 2005 · national
Continuity (1)
Related Publication 20090203618A1 · Aug 13, 2009